These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [Abstract] [Full Text] [Related]
7. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA. Cancer Res; 1995 Aug 15; 55(16):3598-603. PubMed ID: 7543017 [Abstract] [Full Text] [Related]
9. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW. Cancer Res; 1988 Jul 15; 48(14):4107-12. PubMed ID: 3164256 [Abstract] [Full Text] [Related]
13. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients. Shively JE, Spayth V, Chang FF, Metter GE, Klein L, Presant CA, Todd CW. Cancer Res; 1982 Jun 15; 42(6):2506-13. PubMed ID: 7074626 [Abstract] [Full Text] [Related]
18. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer. Björklund V, Björklund B. Cancer Detect Prev; 1983 Jun 15; 6(1-2):193-8. PubMed ID: 6883380 [Abstract] [Full Text] [Related]